US Patent Issued to Temple University-Of The Commonwealth System of Higher Education on June 24 for "5-hydroxytryptamine receptor 7 modulators and their use as therapeutic agents" (Pennsylvania Inventors)

ALEXANDRIA, Va., June 25 -- United States Patent no. 12,338,245, issued on June 24, was assigned to Temple University-Of The Commonwealth System of Higher Education (Philadelphia).

"5-hydroxytryptamine receptor 7 modulators and their use as therapeutic agents" was invented by Benjamin E. Blass (Eagleville, Pa.), Daniel J. Canney (Ambler, Pa.) and Kevin M. Blattner (Folsom, Pa.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Pharmaceutical compositions of the invention comprise functionalized lactone derivatives having a disease-modifying action in the treatment of diseases associated with dysregulation of 5-hydroxytryptamine receptor 7 activity."

The patent was filed on Sept. 27, 2023, under Application No. ...